Supplementary Figure 1: AGS-22M6E ADC specific localization in tumor xenografts. AG-B1 tumor pieces were implanted in ICR-SCID mice subcutaneously.

Slides:

Advertisements

Similar presentations

Supplement Figure 1 Pharmacokinetic profile of PF was evaluated in nude mice. Mice were treated with 1 and 10 mg/kg PF via sc and iv.

Advertisements

Toxicokinetic Calculations

INTRAVENOUS INFUSION.

Supplementary Figures&Legends. Figure1. Subcutaneous xenograft tumor models of the control group.

Noncompartmental Models. Introduction The noncompartmental approach for data analysis does not require any specific compartmental model for the system.

A B PC9 PC9/gef B4 Supplementary Figure S1

Supplementary Methods

Application of Polyglycerol Coating to Plasmid DNA Lipoplex for the Evasion of the Accelerated Blood Clearance Phenomenon in Nucleic Acid Delivery Amr.

Chapter 7 COMPARTMENT MODELS

Cantharidin Inhibits the Growth of Triple-Negative Breast Cancer Cells by Suppressing Autophagy and Inducing Apoptosis in Vitro and in.

Neal et al.Supplementary Figure S1

Figure 1. Herbacetin binds to AKT1/2 and suppresses each respective kinase activity. The effect of herbacetin on (A) PI3K/AKT and (B) MAPK signaling pathway.

Suppl. Fig. 1 A B C No tumor - +

Molecular Therapy - Methods & Clinical Development

Figure 1. Herbacetin binds to AKT1/2 and suppresses each respective kinase activity. The effect of herbacetin on (A) PI3K/AKT and (B) MAPK signaling pathway.

A Untreated mM maphos, 48h 20 mM maphos, 48h 50 mM maphos, 48hh B

Supplementary Table 1: primer sequences

SCC244 significantly inhibited c-Met–driven tumor growth in cancer CDX models. SCC244 significantly inhibited c-Met–driven tumor growth in cancer CDX models.

An anti-CD20–IL-2 immunocytokine is highly efficacious in a SCID mouse model of established human B lymphoma by Stephen D. Gillies, Yan Lan, Steven Williams,

Potent Therapeutic Activity Against Peritoneal Dissemination and Malignant Ascites by the Novel Anti-Folate Receptor Alpha Antibody KHK2805 Munetoshi.

Volume 25, Issue 2, Pages (August 2006)

Figure 3 Methods to detect trough levels of therapeutic antibodies

Volume 10, Issue 4, Pages (April 1999)

Long-term analgesic effect of a single dose of anti-NGF antibody on pain during motion without notable suppression of joint edema and lesion in a rat.

Anti-DNA autoantibodies initiate experimental lupus nephritis by binding directly to the glomerular basement membrane in mice Meera R. Krishnan, Congmiao.

by Rong Deng, and Joseph P. Balthasar

Volume 15, Issue 2, Pages (February 2007)

Volume 158, Issue 6, Pages (September 2014)

Supplementary Table 1 Akt2 is required for NNK-induced lung tumorigenesis but not for urethane-induced lung tumorigenesis while Akt3 may act as a tumor.

Arctigenin inhibits prostate tumor cell growth in vitro and in vivo

Molecular Therapy - Nucleic Acids

Brian Hutzen, Chun-Yu Chen, Pin-Yi Wang, Les Sprague, Hayley M

Volume 19, Issue 3, Pages (March 2017)

Volume 9, Issue 3, Pages (March 2004)

SDC 2 - Figure S1.

Hypersensitivity and Loss of Disease Site Targeting Caused by Antibody Responses to PEGylated Liposomes Adam Judge, Kevin McClintock, Janet R. Phelps,

Combining the Multitargeted Tyrosine Kinase Inhibitor Vandetanib with the Antiestrogen Fulvestrant Enhances Its Antitumor Effect in Non-small Cell Lung.

NRP2 represses IGF-IR expression and signaling.

Fig. 4. Antitumor efficacy of ERY974 against various cancer types.

Inhibition of FGFR signaling and tumor growth in SNU-16 xenograft model by administration of E7090. Inhibition of FGFR signaling and tumor growth in SNU-16.

Inhibiting MDM2-p53 Interaction Suppresses Tumor Growth in Patient-Derived Non– Small Cell Lung Cancer Xenograft Models Josephine Hai, PhD, Shingo Sakashita,

Molecular Therapy - Oncolytics

Volume 21, Issue 8, Pages (November 2017)

Volume 24, Issue 5, Pages (May 2016)

Development of a Hyaluronan Targeted Contrast Reagent for the Demarcation of Melanoma Margins In Vivo S.R. Rudrabhatla, W. Matthew Petroll, Christie.

miR-124 Inhibits Lung Tumorigenesis Induced by K-ras Mutation and NNK

Anti-tumor effect of anti-PD-1 antibody against SCC3 tumor

Histone Deacetylase Inhibitor Romidepsin Enhances Anti-Tumor Effect of Erlotinib in Non-small Cell Lung Cancer (NSCLC) Cell Lines Wei Zhang, PhD, Michael.

Volume 19, Issue 5, Pages (November 2003)

Volume 24, Issue 3, Pages (March 2006)

Thomas S. Griffith, Elizabeth L. Broghammer Molecular Therapy

Enzyme Linked Immuno sorbent Assay

Volume 20, Issue 2, Pages (February 2012)

Anti-CD20 CAR exPBNK significantly inhibit growth of Raji cells in xenografted mice. Anti-CD20 CAR exPBNK significantly inhibit growth of Raji cells in.

Volume 20, Issue 5, Pages (May 2012)

IL-12 affects Dermatophagoides farinae–induced IL-4 production by T cells from pediatric patients with mite-sensitive asthma Takeshi Noma, MD, PhD, Izumi.

Molecular Therapy - Oncolytics

Volume 29, Issue 6, Pages (June 2016)

Volume 19, Issue 6, Pages (June 2011)

Hypersensitivity and Loss of Disease Site Targeting Caused by Antibody Responses to PEGylated Liposomes Adam Judge, Kevin McClintock, Janet R. Phelps,

CD8+ T cells were immunomodulated and required for the efficacy of anti–4-1BB/anti–PD-1 combination treatment. CD8+ T cells were immunomodulated and required.

Volume 16, Issue 10, Pages (October 2008)

CAT displays very high in vivo stability as exemplified by a rat PK study. CAT displays very high in vivo stability as exemplified by a rat.

Volume 25, Issue 2, Pages (February 2017)

Molecular Therapy - Oncolytics

MGA271 exhibits potent in vivo antitumor activity toward tumor cell carcinoma xenografts. MGA271 exhibits potent in vivo antitumor activity toward tumor.

BMX is a driver of castration resistance in vitro and in vivo.

Ganetespib suppresses tumor growth and extends survival in ALK+ NSCLC xenografts. Ganetespib suppresses tumor growth and extends survival in ALK+ NSCLC.

Molecular Therapy - Nucleic Acids

TAMs upregulate DNMT1 in gastric cancer cells through the CCL5/CCR5/STAT3 pathway. TAMs upregulate DNMT1 in gastric cancer cells through the CCL5/CCR5/STAT3.

Presentation transcript:

Supplementary Figure 1: AGS-22M6E ADC specific localization in tumor xenografts. AG-B1 tumor pieces were implanted in ICR-SCID mice subcutaneously. When tumors reached approximately 200 mm3 in volume, mice were untreated (A), treated intravenously with 10 mg/kg isotype control ADC (B, C, D) or treated with AGS-22M6E (E, F, G). Mice were sacrificed at the indicated time points. FFPE specimens were prepared from excised tumors. FFPE sections were stained with the anti-MMAE antibody SG15-22 and detection was performed using the Biogenex Super Sensitive Polymer-HRP IHC Detection Kit.

Non-treated A. Control ADC treated AGS-22M6E treated 6hrs B. E. 24 hrs C. F. 72 hrs D. G.

Supplementary Figure 2: Serum Concentration time profiles for AGS-22M6E and ASG-22CE (A) ADC and (B) Total IgG. AGS-22M6E and ASG-22CE were administered via single intravenous bolus injection into ICR SCID mice at a dose of 10 mg/kg. Sera was collected from whole blood at various time points (n=4/group). A quantitative sandwich enzyme linked immunoassay (ELISA) was used to measure the amount of total IgG antibody and the amount of ADC in the serum samples by capturing with an anti-idiotype antibody and anti-MMAE antibody, respectively.

A. ADC B. Total IgG

Supplementary Table 1: Non Compartmental Toxicokinetic parameters in ICR SCID mice following a single IV bolus injection of AGS-22M6E and ASG-22CE at 10 mg/kg. Assay Antibody T1/2 (day) Cmax (µg/mL) AUClast (day*µg/mL) AUCinf (day*µg/mL) Vss (mL/kg) CL (mL/day/kg) ADC AGS-22M6E 1.53 135 336 339 78.1 29.4 ASG-22CE 1.72 177 324 329 82.4 30.3 Total IgG 1.73 148 363 370 82.1 27.0 2.08 200 349 87.1 28.6 Mean ADC and Total IgG serum concentration obtained following single dose was analyzed by non-compartmental methods using WinNonlin Pro version 5.2.1. (Pharsight Corp., Mountain View, CA). T1/2: elimination half-life; Cmax: maximum concentration observed; AUClast: Area under the curve from time zero to last observable time point; AUCinf: Area under the curve from time zero to infinity; Vss: volume of distribution at steady state; CL: clearance